Series B Investors & VC Firms in Israel

149 firms in this list, with a median first check of $1M. 16 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AT Atomico NZAHBBCB11 people	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
IN INcapital Ventures IHNNELAW6 people	88🔒	Toronto	CA	Series A–Series B	—	+ Add to CRM
RA Radiant Tech Ventures CCGYMCCH9 people	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
SB SBVA CJJDJCJL11 people	88🔒	Seoul	KR	Seed–Series B	$1M – $2.5M	+ Add to CRM
VE Vertex Ventures HC CBLHSCAC5 people	88🔒	San Francisco	US	Seed–Growth	$500K – $10M	+ Add to CRM
AT Atlantic Vantage Point ASBFDMFR11 people	88🔒	Paris	FR	Seed–Late Stage	$1M – $20M	+ Add to CRM
DA Dawn Capital LLP DCEPHOHM11 people	88🔒	London	GB	Series A–Series B	$317.5K – $6.3M	+ Add to CRM
EQ EQT Life Sciences APFVFAJR11 people	88🔒	Amsterdam	NL	Series A–Late Stage	$10.8M – $64.8M	+ Add to CRM
FL Flashpoint Venture Capital AKAFDMIB11 people	88🔒	London	GB	Seed–Late Stage	$1M – $15M	+ Add to CRM
HE Hercules Capital, Inc. BJCJGPJB11 people	88🔒	San Mateo	US	Seed–Late Stage	$500K – $50M	+ Add to CRM
JJ JJDC FMHPLTTM11 people	88🔒	New Brunswick	US	Seed–Series B	$500K – $5M	+ Add to CRM
CI Citi Ventures AMBOJFJZ10 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
CO Coinbase Ventures SA1 person	88🔒	Stamford	US	Pre-Seed–Growth	—	+ Add to CRM
MA Magenta Venture Partners MMOIRL3 people	88🔒	Herzliya	IL	Seed–Series B	—	+ Add to CRM
RA Rabo Corporate Venturing DVFOKLSS10 people	88🔒	Utrecht	NL	Seed–Series B	$1.1M – $4.3M	+ Add to CRM
GR Greenfield Partners YDAERMSG11 people	88🔒	New York	US	Series B–Late Stage	—	+ Add to CRM
SW Swisscom Ventures ASPLSKJM9 people	88🔒	Zürich	CH	Seed–Series B	$1M – $20M	+ Add to CRM
CR Crew Capital BDDDSD3 people · Leads rounds	88🔒	New York	US	Pre-Seed–Series B	$500K – $2M	+ Add to CRM
CI CIVC SRHRNARA6 people	88🔒	Costa Mesa	US	Seed–Late Stage	—	+ Add to CRM
DS dsm-firmenich Venturing SHAKADAM9 people	88🔒	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
RE REV Venture Partners KBTADN3 people	88🔒	San Francisco	US	Seed–Late Stage	$1M – $10M	+ Add to CRM
VE Vertex Growth HCJLCTHC5 people	88🔒	Singapore	SG	Series A–Growth	—	+ Add to CRM
AR Arkin Capital MAALNSPO11 people	88🔒	Herzliya	IL	Seed–Late Stage	—	+ Add to CRM
EU Eurazeo AACMESEL11 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM

Atomico

LondonSeed–Late Stage

NZAHBBCB11 people

INcapital Ventures

TorontoSeries A–Series B

IHNNELAW6 people

Radiant Tech Ventures

Hong KongSeed–Growth

CCGYMCCH9 people

SBVA

SeoulSeed–Series B$1M – $2.5M

CJJDJCJL11 people

Vertex Ventures HC

San FranciscoSeed–Growth$500K – $10M

CBLHSCAC5 people

Atlantic Vantage Point

ParisSeed–Late Stage$1M – $20M

ASBFDMFR11 people

Dawn Capital LLP

LondonSeries A–Series B$317.5K – $6.3M

DCEPHOHM11 people

EQT Life Sciences

AmsterdamSeries A–Late Stage$10.8M – $64.8M

APFVFAJR11 people

Flashpoint Venture Capital

LondonSeed–Late Stage$1M – $15M

AKAFDMIB11 people

Hercules Capital, Inc.

San MateoSeed–Late Stage$500K – $50M

BJCJGPJB11 people

JJDC

New BrunswickSeed–Series B$500K – $5M

FMHPLTTM11 people

Citi Ventures

New YorkSeed–Late Stage

AMBOJFJZ10 people

Coinbase Ventures

StamfordPre-Seed–Growth

SA1 person

Magenta Venture Partners

HerzliyaSeed–Series B

MMOIRL3 people

Rabo Corporate Venturing

UtrechtSeed–Series B$1.1M – $4.3M

DVFOKLSS10 people

Greenfield Partners

New YorkSeries B–Late Stage

YDAERMSG11 people

Swisscom Ventures

ZürichSeed–Series B$1M – $20M

ASPLSKJM9 people

Crew Capital

New YorkPre-Seed–Series B$500K – $2M

BDDDSD3 people

CIVC

Costa MesaSeed–Late Stage

SRHRNARA6 people

dsm-firmenich Venturing

MaastrichtPre-Seed–Late Stage$108K – $5.4M

SHAKADAM9 people

REV Venture Partners

San FranciscoSeed–Late Stage$1M – $10M

KBTADN3 people

Vertex Growth

SingaporeSeries A–Growth

HCJLCTHC5 people

Arkin Capital

HerzliyaSeed–Late Stage

MAALNSPO11 people

Eurazeo

ParisSeries A–Late Stage

AACMESEL11 people

Data sourced from public filings and firms' own websites — see our methodology.